EE200200565A - Vaskulaarse kahjustava toimega kombinatsioonravi - Google Patents

Vaskulaarse kahjustava toimega kombinatsioonravi

Info

Publication number: EE200200565A
Authority: EE; Estonia
Prior art keywords: adverse effects; combination therapy; vascular; taxane; warm
Prior art date: 2000-03-31

Application number

EEP200200565A

Other languages

English (en)

Estonian (et)

Inventor

David Davis Peter

Dougherty Graeme

Original Assignee

Angiogene Pharmaceuticals Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-31

Filing date

2001-02-27

Publication date

2004-06-15

2000-03-31 Priority claimed from GB0007740A external-priority patent/GB0007740D0/en

2000-06-08 Priority claimed from GB0013927A external-priority patent/GB0013927D0/en

2000-06-20 Priority claimed from GB0014908A external-priority patent/GB0014908D0/en

2001-02-27 Application filed by Angiogene Pharmaceuticals Ltd. filed Critical Angiogene Pharmaceuticals Ltd.

2004-06-15 Publication of EE200200565A publication Critical patent/EE200200565A/xx

Links

230000002792 vascular Effects 0.000 title abstract 3
230000002411 adverse Effects 0.000 title 1
238000002648 combination therapy Methods 0.000 title 1
230000000694 effects Effects 0.000 title 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
241001465754 Metazoa Species 0.000 abstract 3
238000004519 manufacturing process Methods 0.000 abstract 3
229940123237 Taxane Drugs 0.000 abstract 2
239000002246 antineoplastic agent Substances 0.000 abstract 2
230000000254 damaging effect Effects 0.000 abstract 2
229910052697 platinum Inorganic materials 0.000 abstract 2
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 2
238000002560 therapeutic procedure Methods 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
230000005865 ionizing radiation Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Glass Compositions (AREA)

EEP200200565A 2000-03-31 2001-02-27 Vaskulaarse kahjustava toimega kombinatsioonravi EE200200565A (et)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0007740A GB0007740D0 (en)	2000-03-31	2000-03-31	Combination therapy
GB0013927A GB0013927D0 (en)	2000-06-08	2000-06-08	Combination therapy
GB0014908A GB0014908D0 (en)	2000-06-20	2000-06-20	Combination therapy
PCT/GB2001/001317 WO2001074368A1 (en)	2000-03-31	2001-03-27	Combination therapies with vascular damaging activity

Publications (1)

Publication Number	Publication Date
EE200200565A true EE200200565A (et)	2004-06-15

Family

ID=27255634

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200565A EE200200565A (et)	2000-03-31	2001-02-27	Vaskulaarse kahjustava toimega kombinatsioonravi

Country Status (23)

Country	Link
US (2)	US6906048B2 (de)
EP (1)	EP1272199B1 (de)
JP (1)	JP2003528920A (de)
KR (1)	KR20020087456A (de)
CN (1)	CN1430515A (de)
AT (1)	ATE287267T1 (de)
AU (2)	AU4258101A (de)
BR (1)	BR0109672A (de)
CA (1)	CA2402539A1 (de)
CZ (1)	CZ20023228A3 (de)
DE (1)	DE60108489T2 (de)
EE (1)	EE200200565A (de)
ES (1)	ES2236199T3 (de)
HU (1)	HUP0300290A3 (de)
IL (1)	IL151628A0 (de)
IS (1)	IS6558A (de)
MX (1)	MXPA02009604A (de)
NO (1)	NO20024646L (de)
NZ (1)	NZ521025A (de)
PL (1)	PL366379A1 (de)
PT (1)	PT1272199E (de)
SK (1)	SK13912002A3 (de)
WO (1)	WO2001074368A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070021392A1 (en) *	2000-03-31	2007-01-25	Davis Peter D	Divided dose therapies with vascular damaging activity
GB0011903D0 (en) *	2000-05-18	2000-07-05	Astrazeneca Ab	Combination chemotherapy
FR2834641B1 (fr) *	2002-01-14	2005-04-22	Ct Regional De Lutte Contre Le	Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
CN100352441C (zh) *	2002-04-16	2007-12-05	阿斯特拉曾尼卡有限公司	用于治疗肿瘤的zd6126和zd1839的联合药物
GB0223379D0 (en) *	2002-10-09	2002-11-13	Angiogene Pharm Ltd	Combination therapy
FR2848212B1 (fr) *	2002-12-06	2006-10-27	Aventis Pharma Sa	Derives de la colchicine, procede de preparation, produits obtenus par ce procede et utilisation
KR20060036058A (ko) *	2003-06-18	2006-04-27	앤지오젠 파마슈티칼스 리미티드	결장직장암의 치료를 위한 혈관 손상 활성을 갖는 5ｆｕ,ｃｐｔ-11 또는 5-ｆｕ 및 ｃｐｔ-11과 함께 ｚｄ6126을포함하는 조성물
GB0316123D0 (en) *	2003-07-10	2003-08-13	Astrazeneca Ab	Combination therapy
US9149489B2 (en) *	2006-04-27	2015-10-06	Board Of Regents, University Of Texas System	Inhibitors of glycolysis useful in the treatment of brain tumors
US8178564B2 (en) *	2006-11-06	2012-05-15	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8173686B2 (en)	2006-11-06	2012-05-08	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8168662B1 (en)	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8168661B2 (en) *	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) *	2009-08-05	2011-02-10	Poniard Pharmaceuticals, Inc.	Stabilized picoplatin oral dosage form
US20100260832A1 (en) *	2007-06-27	2010-10-14	Poniard Pharmaceuticals, Inc.	Combination therapy for ovarian cancer
TW200916094A (en) *	2007-06-27	2009-04-16	Poniard Pharmaceuticals Inc	Stabilized picoplatin dosage form
JP2010533714A (ja) *	2007-07-16	2010-10-28	ポニアードファーマシューティカルズ，インコーポレイテッド	ピコプラチンのための経口製剤
AU2009210656A1 (en) *	2008-02-08	2009-08-13	Poniard Pharmaceuticals, Inc.	Use of picoplatin and cetuximab to treat colorectal cancer
TWI492759B (zh) *	2008-03-05	2015-07-21	Otsuka Pharma Co Ltd	膽甾烷醇衍生物之併用用途
WO2010005799A2 (en)	2008-07-11	2010-01-14	Board Of Regents, The University Of Texas System	Novel acetates of 2-deoxy monosaccharides with anticancer activity
KR101106214B1 (ko) *	2011-04-04	2012-01-20	홍오성	감귤 내껍질 분리 장치
EP2981270B1 (de)	2013-04-05	2021-08-25	Board of Regents, The University of Texas System	Ester von 2-deoxy-monosacchariden mit antiproliferativer wirkung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9714249D0 (en) *	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
WO1999065515A2 (en) *	1998-06-15	1999-12-23	Arch Development Corporation	Combination of radiotherapy and anti-angiogenic factors
GB9903404D0 (en)	1999-02-16	1999-04-07	Angiogene Pharm Ltd	Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
ATE298240T1 (de)	2000-03-31	2005-07-15	Angiogene Pharm Ltd	Getrennte dosis therapien mit gefässschädigender aktivität

2001
- 2001-02-27 EE EEP200200565A patent/EE200200565A/xx unknown
- 2001-03-27 EP EP01915490A patent/EP1272199B1/de not_active Expired - Lifetime
- 2001-03-27 IL IL15162801A patent/IL151628A0/xx unknown
- 2001-03-27 MX MXPA02009604A patent/MXPA02009604A/es unknown
- 2001-03-27 SK SK1391-2002A patent/SK13912002A3/sk not_active Application Discontinuation
- 2001-03-27 AU AU4258101A patent/AU4258101A/xx active Pending
- 2001-03-27 CZ CZ20023228A patent/CZ20023228A3/cs unknown
- 2001-03-27 AT AT01915490T patent/ATE287267T1/de not_active IP Right Cessation
- 2001-03-27 PT PT01915490T patent/PT1272199E/pt unknown
- 2001-03-27 NZ NZ521025A patent/NZ521025A/en unknown
- 2001-03-27 CA CA002402539A patent/CA2402539A1/en not_active Abandoned
- 2001-03-27 JP JP2001572111A patent/JP2003528920A/ja active Pending
- 2001-03-27 BR BR0109672-9A patent/BR0109672A/pt not_active IP Right Cessation
- 2001-03-27 KR KR1020027013061A patent/KR20020087456A/ko not_active Ceased
- 2001-03-27 US US10/240,213 patent/US6906048B2/en not_active Expired - Fee Related
- 2001-03-27 HU HU0300290A patent/HUP0300290A3/hu unknown
- 2001-03-27 WO PCT/GB2001/001317 patent/WO2001074368A1/en not_active Ceased
- 2001-03-27 AU AU2001242581A patent/AU2001242581B2/en not_active Ceased
- 2001-03-27 CN CN01807444A patent/CN1430515A/zh active Pending
- 2001-03-27 ES ES01915490T patent/ES2236199T3/es not_active Expired - Lifetime
- 2001-03-27 PL PL01366379A patent/PL366379A1/xx not_active Application Discontinuation
- 2001-03-27 DE DE60108489T patent/DE60108489T2/de not_active Expired - Fee Related
2002
- 2002-09-20 IS IS6558A patent/IS6558A/is unknown
- 2002-09-27 NO NO20024646A patent/NO20024646L/no unknown
2004
- 2004-11-23 US US10/994,639 patent/US20050107346A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE287267T1 (de)	2005-02-15
HUP0300290A2 (hu)	2003-06-28
CN1430515A (zh)	2003-07-16
DE60108489D1 (de)	2005-02-24
EP1272199A1 (de)	2003-01-08
HUP0300290A3 (en)	2005-12-28
CZ20023228A3 (cs)	2003-01-15
PT1272199E (pt)	2005-05-31
DE60108489T2 (de)	2006-03-30
AU4258101A (en)	2001-10-15
US20030166617A1 (en)	2003-09-04
SK13912002A3 (sk)	2003-05-02
NZ521025A (en)	2005-06-24
EP1272199B1 (de)	2005-01-19
US6906048B2 (en)	2005-06-14
NO20024646L (no)	2002-10-15
MXPA02009604A (es)	2003-03-10
PL366379A1 (en)	2005-01-24
CA2402539A1 (en)	2001-10-11
IL151628A0 (en)	2003-04-10
WO2001074368A1 (en)	2001-10-11
KR20020087456A (ko)	2002-11-22
AU2001242581B2 (en)	2005-03-03
US20050107346A1 (en)	2005-05-19
NO20024646D0 (no)	2002-09-27
JP2003528920A (ja)	2003-09-30
ES2236199T3 (es)	2005-07-16
IS6558A (is)	2002-09-20
BR0109672A (pt)	2003-02-04

Legal Events

Date	Code	Title	Description
2007-12-17	HF1A	Correction of a date

Publication	Publication Date	Title
EE200200565A (et)	2004-06-15	Vaskulaarse kahjustava toimega kombinatsioonravi
CY1116463T1 (el)	2017-03-15	Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
NO20050807L (no)	2005-02-15	Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
DK1346041T3 (da)	2007-07-02	Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
NO20062504L (no)	2006-07-21	Sammensetninger og doseringsformer for forbedret absorpsjon
CY1109242T1 (el)	2014-07-02	Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
EA200501849A1 (ru)	2006-06-30	Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
NO20071426L (no)	2007-06-18	Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
WO2004045593A3 (en)	2004-08-12	Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
BR0314797A (pt)	2005-07-26	Derivados da pirimidineamida e o uso dos mesmos
NO20044498L (no)	2004-11-04	Kombinasjonsterapi for behandling av cancer
EA200801731A1 (ru)	2009-10-30	Составы и способы лечения тробмоцитемии
NO20031410D0 (no)	2003-03-27	Antitumorterapi innbefattende distamycinderivater
NO20064753L (no)	2006-10-20	Kombinasjonsterapi
EE200200549A (et)	2004-02-16	Jagatud doosi teraapia veresooni kahjustava aktiivsusega
ATE413187T1 (de)	2008-11-15	Pharmazeutische zusammensetzungen mit interferon- tau
DE60309926D1 (de)	2007-01-04	Steroid-verbindungen mit anti-tumoraler wirkung
WO2005035500A3 (en)	2005-05-19	Therapeutic agents useful for treating pain
FR2809725B1 (fr)	2004-05-07	Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
TW200500073A (en)	2005-01-01	Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof